VanEck Ethereum ETF VanEck Ethereum ETF (BATS: ETHV)

에 대한 최신 뉴스 VanEck Ethereum ETF VanEck Ethereum ETF (BATS:ETHV)

The Trust is a passive investment vehicle that does not seek to pursue any investment strategy beyond tracking the price of ETH

VanEck Ethereum ETF

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Sector ETFs

ETFs

$BTC

$ETH

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

ETHA

ETHV

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

IBIT

비트코인(CRYPTO: BTC)과 이더리움(CRYPTO: ETH) 현물 ETF는 지난 4일 동안 각각 32억 6천만 달러와 7,443만 달러의 유입을 기록했다.

비트코인·이더리움 ETF, 시장 변동성과 정책 불확실성에도 기록적 자금 유입 발생

VanEck Ethereum ETF VanEck Ethereum ETF

WIIM

QNRX

Quoin Pharmaceuticals shares are trading higher after the company announced it advanced its Netherton syndrome treatment and is partnering with Skinvisible to seek FDA-approved topical innovation.

Shares of Li-Metal batteries manufacturer SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) are trading higher in premarket on Thursday.
SES AI has signed contracts valued at up to $10 million with two prominent global OEM partners, marking a milestone in utilizing AI for the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43155807/ses-ai-signs-contracts-totaling-up-to-10-million-to-develop-ai-enhanced-li-metal-and-li-ion-batter" rel="noreferrer noopener">discovery of battery materials.</a>
These agreements aim to develop electrolyte materials for Li-Metal and Li-ion batteries in automotive applications.
SES AI said that a portion of the revenue from these contracts will be recognized in the fourth quarter of 2024, with the rest expected to be acknowledged by mid-2025.
These latest agreements with OEM partners build on the company&#8217;s prior announcement of the first battery to use an electrolyte material discovered through its AI-based Molecular Universe project.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/01/43127666/uber-eats-partners-with-home-depot-for-on-demand-deliveries" rel="noreferrer noopener">Uber Eats Partners With Home Depot For On-Demand Deliveries</a>
&#8220;These new contracts with our automotive OEM partners are applying our AI-discovered electrolytes for Li-Metal B-sample developments and for the first time with mature Li-ion batteries already in commercial use,&#8221; said Founder and CEO Qichao Hu.
&#8220;We believe this new revenue stream and these contracts validate and accelerate the commercial use of AI for Science for battery material discovery in automotive applications.&#8221;
Price Action: SES shares are trading higher by 20% at $0.9975 in premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43121964/adidas-sees-solid-gains-in-q4-looks-to-expand-market-share" target="_blank" rel="noreferrer noopener">Adidas Sees Solid Gains In Q4, Looks To Expand Market Share</a></li>
</ul>
Image via Shutterstock.

Equities

News

Contracts

Movers

SES Secures ~$10M In AI-Powered Battery Contracts; Stock Jumps

Wolfe Research analyst Steve Fleishman downgrades FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) from Outperform to Peer Perform.

Downgrades

Analyst Ratings

Wolfe Research Downgrades FirstEnergy to Peer Perform

B of A Securities analyst Christopher Nardone maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Neutral and raises the price target from $182 to $217.

Price Target

DECK

B of A Securities Maintains Neutral on Deckers Outdoor, Raises Price Target to $217

Aptiv PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) disclosed that its Board of Directors has approved a plan to separate its Electrical Distribution Systems (EDS) business from Aptiv, creating two <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43124298/aptiv-unplugs-eds-spin-off-aims-to-supercharge-electrification-automation-and-ai">independent entities</a>.
Aptiv also reaffirmed its 2024 outlook, with a fourth-quarter earnings report scheduled for February 6, 2025. While reporting third-quarter results in October, Aptiv said it expects FY24 adjusted earnings per share in the range of $6.00-$6.30 ($6.12 estimate) and net sales of $19.60 billion-$19.90 billion ($19.68 billion estimate).
Kevin Clark, Aptiv's Chairman and CEO, emphasized that the separation is part of the company's broader transformation strategy.
"Following completion of the transaction, Aptiv will have a portfolio of advanced software and hardware technologies and highly engineered, mission-critical products that are aligned with global mega trends fueling growth in diverse end markets," Clark said.
Aptiv's shares gained 1.5% to close at $62.73 on Wednesday.
These analysts made changes to their price targets on Aptiv following the announcement.
<ul>
<li>Piper Sandler analyst Alexander Potter upgraded Aptiv from Underweight to Neutral and raised the price target from $53 to $65.</li>
<li>Baird analyst David Leiker maintained the stock with a Neutral and raised the price target from $70 to $75.</li>
</ul>
Considering buying APTV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="596" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23082510/image-175-1024x596.png" alt="" class="wp-image-746807" style="width:503px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23082510/image-175-1024x596.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23082510/image-175-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23082510/image-175-768x447.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23082510/image-175.png 1086w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

APTV

These Analysts Boost Their Forecasts On Aptiv

B of A Securities analyst Wamsi Mohan maintains Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) with a Neutral and raises the price target from $75 to $85.

B of A Securities Maintains Neutral on Amphenol, Raises Price Target to $85

Citigroup analyst Christopher Allen reinstates Blue Owl Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) with a Buy and announces $30 price target.

Initiation

Citigroup Reinstates Buy on Blue Owl Cap, Announces $30 Price Target

B of A Securities analyst Tim Anderson maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Neutral and lowers the price target from $160 to $159.

B of A Securities Maintains Neutral on Johnson & Johnson, Lowers Price Target to $159

VIGL

Vigil Neuroscience shares are trading higher after the company reported data from its completed Phase 1 clinical trial evaluating VG-3927 for the potential treatment of Alzheimer's disease.

Looking Ahead to 2025
As we enter 2025, we are excited to build on this momentum. Our focus remains on:
<ul>
<li>Identifying key opportunities to advance (Z)-endoxifen into registrational clinical trials with the goal of advancing (Z)-endoxifen to the market in the quickest way possible. This is our company's top priority, and we commit to communicating our progress on this goal in the first quarter of this year.</li>
<li>Amplifying our ongoing business development efforts to ensure women globally have the opportunity to benefit from (Z)-endoxifen.</li>
<li>Deepening collaborations with industry leaders and advocacy groups to broaden the impact of our work.
<ul>
<li>Extending our track record of financial strength that will position us to support our long-term growth.</li>
</ul>
</li>
</ul>

Biotech

General

ATOS

Atossa Therapeutics Says Z-Endoxifen To Enter Registrational Clinical Trials In 2025; Updates On Progress Expected Q1; Global Business Development Efforts Amplified; Industry Partnerships Deepened; Financial Strength For Long-Term Growth Emphasized

B of A Securities analyst Joanna Gajuk maintains Concentra Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>) with a Buy and raises the price target from $24 to $25.

B of A Securities Maintains Buy on Concentra Group Holdings, Raises Price Target to $25

McCormick &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) reported&nbsp;fourth-quarter sales growth of 3% year-on-year to $1.798 billion, beating the analyst consensus <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43155089/mccormick-reports-strong-2024-financial-results-and-provides-2025-outlook" rel="noreferrer noopener">estimate of $1.77 billion</a>.
Flavor Solutions segment sales grew by 1%, with minimal impact from currency. Consumer segment sales increased 4%.
Gross profit was $722.2 million, with the margin expanding 20 basis points Y/Y to 40.2%.
Operating income rose 3% to $306.2 million and the operating margin remained flat at 17%.
Adjusted EPS of $0.80 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus estimate of $0.77.</a>
McCormick held $186.1 million in cash and equivalents as of November 30, 2024. The company generated an operating cash flow of $922 million in FY24.
&#8220;We are pleased to report strong performance for both fourth quarter and fiscal year 2024, an important year for McCormick, in which we built momentum and strengthened our leadership, returning to differentiated and sustainable volume-led growth,&#8221; said Chairman, President, and CEO Brendan M. Foley.
&#8220;Our strategic investments in core categories enabled us to drive positive volume growth, expand our margins, and deliver robust earnings growth.&#8221;
Outlook: McCormick sees FY25 sales growth of 0% – 2% as reported and 1%&nbsp;&#8211;&nbsp;3% in constant currency. The company expects an adjusted EPS of $3.03 – $3.08 versus the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">estimate of $3.11.</a>
Price Action: MKC shares are trading higher by 2.29% at $71.55 in premarket at last check Thursday.

Earnings

Guidance

McCormick Posts 3% Sales Growth In Q4 As Consumer Demand Rise

SES AI shares are trading higher after the company announced it secured two contracts worth $10 million in total.

The OLB Group, Inc., (NASDAQ:<a href="https://www.benzinga.com/stock/OLB#NASDAQ">OLB</a>), a diversified Fintech eCommerce merchant services provider and Bitcoin mining enterprise, announced today the introduction of a 3D Secure (3DS)  Access Control Service to enhance security for the Company's proprietary Card-Not-Present (CNP)  payment gateway, SecurePay&#x2122;. The Company has integrated and certified SecurePay with major card brands such as Visa, MasterCard and Discover for 3D Secure services.
Key features of SecurePay's 3D Secure solution:
Enhanced Fraud Prevention: OLB's 3DS gateway minimizes the likelihood of fraudulent transactions by implementing real-time authentication protocols.
Enhanced Customer Trust: By providing an additional layer of security, customers feel more assured about their online transactions, which may result in higher conversion rates.
Liability Shift: Using 3DS shifts the liability for fraudulent transactions from merchants to card issuers.
Enhanced fraud protection with dynamic risk rules
Responsibility for chargeback liabilities transitions from businesses to card issuers for authenticated transactions.
Global Acceptance: OLB's 3DS gateway is compatible with major card providers globally, ensuring secure international transactions.
Regulatory Compliance: The system ensures adherence to industry standards like PCI DSS, meeting legal and financial regulations.
Seamless Integration: Facilitates easy implementation with current e-commerce platforms, thereby reducing any potential disruptions to the user experience.
Integration with SecurePay's Ecosystem: As part of OLB Financial Technologies, the 3DS solution provides integration with other SecurePay products and services.
By using this advanced 3D Secure gateway, OLB ensures a safe, efficient, and trustworthy online shopping environment for both merchants and customers.
Mobile Optimization: Supports modern, user-friendly authentication methods for a smooth mobile shopping experience.
3D Secure (3DS) is a global authentication protocol designed to add an extra layer of security to online credit and debit card transactions. Originally developed by Visa and Mastercard, it is now used by major card networks to reduce fraud and enhance the safety of eCommerce payments.

OLB Group Introduces 3D Secure Access Control For SecurePay; Integrates Visa, MasterCard, Discover For Enhanced Fraud Prevention, Liability Shift, Compliance, And Global eCommerce Security.

Baird analyst Colin Sebastian maintains Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) with a Outperform and lowers the price target from $175 to $158.

Baird Maintains Outperform on Electronic Arts, Lowers Price Target to $158

Data shared from phase II NEO trial highlights Guardant Reveal&#x2122; as a decision tool to support organ preservation in rectal cancer
Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>), a leading precision oncology company, today announced the company and its research collaborators will present data showcasing the benefits of Guardant's precision oncology tools across cancer screening, recurrence monitoring, treatment selection and therapy development at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, January 23-25, 2025.
Key focus areas in Guardant's co-authored abstracts and collaborator presentations utilizing Guardant products include the impact of mutations on treatment response in colorectal cancer and biliary tract cancers, and additional support for the benefits of blood-based screening in colorectal, gastric and esophageal cancers. A rapid oral presentation will feature data from the phase II NEO trial highlighting Guardant Reveal as a decision tool to support organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision and observation.

Guardant Health Presents Phase II NEO Trial Data On Guardant Reveal Tool For Organ Preservation In Node-Negative Rectal Cancer At The ASCO GI Symposium

Citigroup analyst Andrew Kaplowitz maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Neutral and raises the price target from $361 to $437.

Citigroup Maintains Neutral on GE Vernova, Raises Price Target to $437

Sellas Life Sciences shares are trading higher after the company announced interim analysis results from its Phase 3 REGAL trial of GPS in acute myeloid leukemia.

Bolivia, the owner of the world's largest lithium reserves, is trying to capitalize on this valuable resource. Despite prices plummeting from 2022 highs, the country is pushing forward with large-scale investments to take advantage of the <a target="_blank" href="https://www.benzinga.com/topic/battery" rel="noreferrer noopener">growing battery industry</a>.
"With the two new contracts, we plan to reach 49,000 tons of lithium carbonate annually within three years," Omar Alarcon, president of Bolivia's state-owned lithium company Yacimientos de Litio Bolivianos (YLB) <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-01-21/bolivia-steps-up-lithium-dealmaking-despite-growing-opposition" rel="noreferrer noopener">told</a> Bloomberg.
YLB's deals with Russia's Uranium One Group and a Chinese consortium totaling nearly $2 billion. The agreements include the construction of three processing plants. The Russian-backed facility is set to produce 14,000 tons annually, while the Chinese partnership aims to add 35,000 tons.
Despite holding an estimated 21 million tons of lithium beneath the Uyuni salt flat in the southern region of Potosí, Bolivia's current production is negligible.
Key challenges include the high altitude of its deposits, the logistical constraints of being landlocked, and a high concentration of magnesium in its brine, which complicates extraction.
Together, these hurdles make the production at current prices of around $10,000 per ton barely viable. To address these obstacles, the government is banking on direct lithium extraction technology, which promises to reduce processing times and increase efficiency.
While Bolivia's ambitions are laudable, environmental concerns loom large. Last year, Potosí Senator Elena Aguilar voiced concerns over water usage <a target="_blank" href="https://news.mongabay.com/2024/04/rapid-growth-of-bolivias-lithium-industry-creating-new-problems-for-local-communities/" rel="noreferrer noopener">for</a> Mongabay.
"We want to see the industrialization of lithium, but it has to be done responsibly for the sake of our natural resources." A 2024 inspection by the Regional Federation of Workers and Peasants of the Southern Altiplano found operational inefficiencies at existing facilities. Equipment at a lithium carbonate plant remained unpacked, and power shortages were hampering progress. Moreover, a potassium chloride plant, designed for 350,000 tons of annual production managed only 80,000 tons, raising doubts about Bolivia's industrial readiness.
Still, the industry's problems extend far beyond emerging markets. A <a target="_blank" href="https://pdf.sciencedirectassets.com/319959/1-s2.0-S2589811624X00051/1-s2.0-S2589811625000011/main.pdf" rel="noreferrer noopener">research paper</a> by Johnson, Park, and Kramarz critiques the lack of credible governance mechanisms in the lithium sector, pointing out that voluntary and hybrid regulatory measures often fail to prevent environmental harm or ensure community participation.
The authors stress that effective governance must include stringent monitoring, local engagement, and enforceable penalties for non-compliance—a long shot for a country such as Bolivia, which boasts a Corruption Perceptions Index of 29, the sixth-worst in the LATAM region.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43142099/trumps-u-turn-on-green-tech-masks-the-long-term-resource-independence-goals" target="_blank" rel="noreferrer noopener">No EV Credits, No Problem: Mining Giants Still See Green In Trump Deregulation Push</a></li>
</ul>
Photo via Shutterstock

Latin America

Financing

Commodities

Bolivia Taps BRICS For Raising $2 Billion, Targets Its Vast Lithium Riches

BNZI

Banzai International shares are trading higher after the company announced the acquisition of Act-On Software.

BlackRock's ETHA leads the pack as first ether ETF to hit $1B in net inflows

Cryptocurrencies: Bitcoin Inches Down To $59K

Monthly Market Recap: Fed Soothes With Future Rate Cuts

Prepare For Election Outcomes: Views From Our Portfolio Managers

Will Fed's easing cycle reverse the tide of ether ETF outflows? Analyst weighs in

3 Roadblocks To Crypto Adoption

Optimal Crypto Allocation For Portfolios

Renaissance Or Prelude To Chaos? Crypto's Role In The Trump Era

Plan For 2025: Predictions From Our Portfolio Managers

The Ethereum Spot ETFs recorded a net weekly outflow of$38.20 million, ending a five-week positive streak.

Ethereum ETFs Record $38 Million Outflows, Break 5-Week Positive Streak

AAAU

AEMB

ANGL

AQWA

AVEM

AVES

AVMU

AYTEF

BATT

BCDF

BCHG

BGLD

BITO

BITQ

BITS

BKCH

BLKC

BLOK

BRRR

BSMO

BSMP

BSMQ

BSMR

BSMS

BSMT

BTCO

BTCW

BTGD

CBON

CEMB

CETH

CLOI

COIN

COPX

CORP

DAPP

DBEM

DEFI

DFEV

DIEM

EBLU

EBND

EFIX

EJUL

EMBD

EMCB

EMCR

EMHC

EMHY

EMLC

EMTL

EMXC

ESGE

ETCG

ETHE

ETHW

EZBC

EZET

FAIL

FALN

FCAL

FCOR

FDIG

FDMO

FEMB

FLCO

FLMB

FLMI

FMAT

FMNY

FRDM

FSMB

FTAG

FTRI

FUMB

GBTC

GDMN

GDXD

GDXJ

GDXU

GFOF

GHYG

GIGB

GLDI

GLDM

GLTR

GOAU

GOEX

GOVZ

GUNR

GURU

HEEM

HMOP

HODL

HYDR

HYEM

HYGH

HYLS

HYXF

HYXU

IAUM

IBLC

IBMM

IBMN

IBMO

Comments

VanEck Ethereum ETF VanEck Ethereum ETF

뉴스

에 대한 최신 뉴스 VanEck Ethereum ETF VanEck Ethereum ETF (BATS:ETHV)

목요일, 1월 23, 2025

뉴스

파트너 / 기고자

벤징가 글로벌